Charité – Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH), and Enterprise Singapore (ESG) are continuing their successful international collaboration. In November 2025, the Memorandum of Understanding (MoU) underpinning their joint co-innovation programme was renewed for…
To ensure that people are not only treated when they are ill, but that diseases do not develop in the first place, medicine must systematically incorporate preventive measures. The BIH Biomedical Innovation Academy (BIA) and Charité – Universitätsmedizin Berlin are launching their Advanced Clinician…
Since the last certificate award ceremony at the International Clinician Scientist Symposium (June 2024), more than 60 program participants have completed their BIH Charité (Junior) (Digital) (Advanced) Clinician Scientist training. This means that the alumni community continues to grow – we are…
This year, the retreat took us and around 150 participants to the “Villa Elisabeth” in Berlin Mitte for an inspiring day. The aim of the one-day CSP retreat was to strengthen the interdisciplinary networking of the fellows. The (Junior) (Digital) Clinician Scientists helped design the program from…
A total of five projects supervised by Charité BIH Innovation — the joint technology transfer of Charité and BIH — have successfully qualified for the GO-Bio initial program of the Federal Ministry of Research, Technology, and Space (BMFTR). While NEUROLITH will begin the two-year feasibility phase…
The Berlin Institute of Health at Charité (BIH) successfully concluded its Digital Health Accelerator Demo Day in October 2025. The virtual event brought together clinicians, researchers, investors, and innovators in digital health to present solutions developed by those working closest to patients.…
In a study published at the end of August in the journal Molecular Therapy, Michael Kaminski, Verena Klämbt, and Matteus Krappitz – all participants of the BIH Charité Clinician Scientist Program – report an advancement in the fight against autosomal dominant polycystic kidney disease (ADPKD). The…
In a study recently published in JACC: Cardiovascular Imaging, PD Dr. Simon Hellwig, Fellow of the BIH Charité Clinician Scientist Program, and Prof. Dr. Jan F. Scheitz, Fellow of the BIH Charité Advanced Clinician Scientist Pilotprogram, report novel insights into the prognostic relevance of…
Following the successful submission of Expressions of Interest, the next steps are underway: together with researchers at Charité and BIH, innovative projects will now be developed.
